Invesco Ltd. Collegium Pharmaceutical, Inc Transaction History
Invesco Ltd.
- $557 Billion
- Q2 2025
A detailed history of Invesco Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Invesco Ltd. holds 1,584,871 shares of COLL stock, worth $60 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,584,871
Previous 1,632,339
2.91%
Holding current value
$60 Million
Previous $48.7 Million
3.82%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding COLL
# of Institutions
242Shares Held
36.4MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$219 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$120 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$100 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$85.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.52MShares$57.6 Million0.06% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.29B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...